CANNABIS USE DISORDERS

Clinical trials for CANNABIS USE DISORDERS explained in plain language.

Never miss a new study

Get alerted when new CANNABIS USE DISORDERS trials appear

Sign up with your email to follow new studies for CANNABIS USE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a diabetes drug curb cannabis cravings? new trial investigates

Disease control Recruiting now

This study tests if semaglutide, a medicine used for diabetes and weight loss, can help adults with cannabis use disorder reduce their cannabis use. About 100 people who want to cut down or stop will receive either semaglutide or a placebo for 20 weeks. The main goal is to see if…

Matched conditions: CANNABIS USE DISORDERS

Phase: PHASE2 • Sponsor: Anders Fink-Jensen, MD, DMSci • Aim: Disease control

Last updated May 17, 2026 08:55 UTC

CANNABIS USE DISORDERS

Get alerted when new CANNABIS USE DISORDERS trials appear

Could a diabetes drug curb cannabis cravings? new trial investigates